Strides forms joint venture with BioChimico in Brazil
This article was originally published in Scrip
Strides Arcolab of India is setting up a joint venture (JV) with Brazil's BioChimico to cater to the Brazilian hospital market. The partners expect the JV to emerge as a leading player in the high-end injectables and anaesthetics sectors in the South American country.
You may also be interested in...
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.